August 15, 2013
Ottawa researchers have developed unique virus-derived particles that can kill human blood cancer cells in the laboratory and eradicate the disease in mice, with few side effects.
The study is published in Blood Cancer Journal (open access) by co-senior authors Drs. David Conrad and John Bell of the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa).
Bell and his colleagues have… read more